A decision on tolebrutinib for treating MS is now set for Sept. 28, after the FDA granted priority review to its approval ...

A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.

FDA grants Priority Review status to Sanofi's tolebrutinib for the treatment of non-relapsing secondary progressive multiple ...

Sanofi (NASDAQ:SNY) said on Tuesday that the US FDA has granted priority review to the regulatory submission of tolebrutinib ...

If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability ...

Reserve Bank of India has issued the revised guidelines on priority sector lending (PSL) after a comprehensive review of ...

The country poured billions into AI infrastructure, but the data center gold rush is unraveling as speculative investments ...

Keeping Idaho’s voter rolls current has been a priority of Secretary of State Phil McGrane and Gov. Brad Little.

All non-folding e-bikes will be banned on London Tube and rail services from the end of the month to ensure the safety of ...

OS 18.4 update to bring new AI features, including expanded language support, smarter notifications and more. (Bloomberg) ...

The U.S. Court of Appeals for the Federal Circuit last week issued an opinion that explained an often misunderstood doctrine ...

Ranchi: In a bid to tackle water scarcity in the summer months, the Ranchi Municipal Corporation (RMC) top brass on Tuesday ...